Intraocular pressure measurements throughout the 24 h

Current Opinion in Ophthalmology

Volumn 20, Issue 2, 2009, Pages 79-83

  Bagga, Harmohina ^a   Liu, John H K ^a   Weinreb, Robert N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Circadian rhythm; Corneal biomechanical properties; Diurnal; Glaucoma; Intraocular pressure; Nocturnal

Indexed keywords

BIMATOPROST; BRIMONIDINE; BRINZOLAMIDE; DORZOLAMIDE; LATANOPROST; TIMOLOL; TRAVOPROST;

ADD ON THERAPY; BIOMECHANICS; CIRCADIAN RHYTHM; CORNEA; DISEASE SEVERITY; GLAUCOMA; HUMAN; HYSTERESIS; INTRAOCULAR PRESSURE; LASER SURGERY; MONOTHERAPY; MORNING DOSAGE; PRIORITY JOURNAL; REVIEW; TRABECULOPLASTY; TREATMENT INDICATION; TREATMENT OUTCOME;

CARBONIC ANHYDRASE INHIBITORS; CIRCADIAN RHYTHM; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; LASER THERAPY; PROSTAGLANDINS; TIMOLOL; TRABECULECTOMY;

EID: 62849111367     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICU.0b013e32831eef4f     Document Type: Review

References (55)

1. Kass MA, Heuer DK, Higginbotham EJ, et al. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002; 120:701-713.
2. Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma: Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol 1998; 126:498-505.
3. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Arch Ophthalmol 2002; 120:1268-1279.
4. Malerbi FK, Hatanaka M, Vessani RM, Susanna R Jr. Intraocular pressure variability in patients who reached target intraocular pressure. Br J Ophthalmol 2005; 89:540-542.
5. Hughes E, Spry P, Diamond J. 24-hour monitoring of intraocular pressure in glaucoma management: a retrospective review. J Glaucoma 2003; 12:232-236.
6. Barkana Y, Anis S, Liebmann J, et al. Clinical utility of intraocular pressure monitoring outside of normal office hours in patients with glaucoma. Arch Ophthalmol 2006; 124:793-797.
7. Liu JH, Kripke DF, Hoffman RE, et al. Nocturnal elevation of intraocular pressure in young adults. Invest Ophthalmol Vis Sci 1998; 39:2707-2712.
8. Liu JH, Kripke DF, Twa MD, et al. Twenty-four-hour pattern of intraocular pressure in the aging population. Invest Ophthalmol Vis Sci 1999; 40:2912-2917.
9. Liu JH, Kripke DF, Twa MD, et al. Twenty-four-hour pattern of intraocular pressure in young adults with moderate to severe myopia. Invest Ophthalmol Vis Sci 2002; 43:2351-2355.
10. Liu JH, Zhang X, Kripke DF, Weinreb RN. Twenty-four-hour intraocular pressure pattern associated with early glaucomatous changes. Invest Ophthalmol Vis Sci 2003; 44:1586-1590.
11. Liu JH, Weinreb RN. Diurnal and nocturnal intraocular pressures in myopic young adults: an update. In: Midena E, editor. Myopia and related diseases. New York: Ophthalmic Communications Society, Inc.; 2005. pp. 370-372.
12. Friberg TR, Sanborn G, Weinreb RN. Intraocular and episcleral venous pressure during inverted posture. Am J Opthalmol 1987; 103:523-526.
13. Liu JH, Bouligny RP, Kripke DF, Weinreb RN. Nocturnal elevation of intraocular pressure is detectable in the sitting position. Invest Ophthalmol Vis Sci 2003; 44:4439-4442.
14. Buguet A, Py P, Romanet JP. 24-hour (nyctohemeral) and sleep-related variations of intraocular pressure in healthy white individuals. Am J Ophthalmol 1994; 117:342-347.
15. De Vivero C, O'Brien C, Lanigan L, Hitchings R. Diurnal intraocular pressure variation in low-tension glaucoma. Eye 1994; 8:521-523.
16. Rota-Bartelink AM, Pitt A, Story I. Influence of diurnal variation on the intraocular pressure measurement of treated primary open-angle glaucoma during office hours. J Glaucoma 1996; 5:410-415.
17. Tajunisah I, Reddy SC, Fathilah J. Diurnal variation of intraocular pressure in suspected glaucoma patients and their outcome. Graefes Arch Clin Exp Ophthalmol 2007; 245:1851-1857.
18. Asrani S, Zeimer R, Wilensky J, et al. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma 2000; 9:134-142.
19. Collaer N, Zeyen T, Caprioli J. Sequential office pressure measurements in the management of glaucoma. J Glaucoma 2005; 14:196-200.
20. Nouri-Mahdavi K, Hoffman D, Coleman A, et al. Predictive factors for glaucomatous visual field progression in the advanced glaucoma intervention study. Ophthalmology 2004; 111:1627-1635.
21. Caprioli J, Coleman AL. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressure in the advanced glaucoma intervention study. Ophthalmology 2008; 115:1123-1129.
22. Medeiros FA, Weinreb RN, Zangwill LM, et al. Long-term intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucoma. Ophthalmology 2008; 115:934-940.
23. Bengtsson B, Heijl A. Diurnal IOP fluctuation: not an independent risk factor for glaucomatous visual field loss in high-risk ocular hypertension. Graefes Arch Clin Exp Ophthalmol 2005; 243:513-518.
24. Bengtsson B, Leske MC, Hyman L, Heijl A, Early Manifest Glaucoma Trial Group. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trail. Ophthalmology 2007; 114:205-209.
25. Sit AJ, Nau CB, McLaren JW, et al. Orcadian variation of aqueous dynamics in young healthy adults. Invest Ophthalmol Vis Sci 2008; 49:1473-1479.
26. Mishima HK, Kiuchi Y, Takamatsu M, et al. Circadian intraocular pressure management with latanoprost: diurnal and nocturnal pressure reduction and increased uveoscleral outflow. Surv Ophthalmol 1997; 41:8139-5144.
27. Orzalesi N, Rossetti L, Invernizzi T, et al. Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension. Invest Ophthalmol Vis Sci 2000; 41:2566-2573.
28. Larsson LI, Mishima HK, Takamatsu M, et al. The effect of latanoprost on circadian intraocular pressure. Surv Ophthalmol 2002; 47:S90-S96.
29. Liu JH, Kripke DF, Weinreb RN. Comparison of nocturnal effects of once-daily timolol and latanoprost on intraocular pressure. Am J ophthalmol 2004; 138:389-395.
30. Sit AJ, Weinreb RN, Crowston JG, et al. Sustained effect of travoprost on diurnal and nocturnal intraocular pressure. Am J Ophthalmol 2006; 141:1131-1133.
31. Liu JHK, Medeiros FA, Slight RJ, Weinreb RN. Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy. Ophthalmology 2008 (in press).
32. Tamer C, Oksüz H. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost. Ophthalmic Res 2007; 39:24-31.
33. Stewart WC, Konstas AG, Nelson LA, Kruft B. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines. Ophthalmology 2008; 115:1117-1122.
34. Lee AC, Mosaed S, Weinreb RN, et al. Effect of laser trabeculoplasty on nocturnal intraocular pressure in medically treated glaucoma patients. Ophthalmology 2007; 114:666-670.
35. Wilensky JT, Zeimer RC, Gieser DK, Kaplan BH. The effects of glaucoma filtering surgery on the variability of diurnal intraocular pressure. Trans Am Ophthalmol Soc 1994; 92:377-381.
36. Medeiros FA, Pinheiro A, Moura FC, et al. Intraocular pressure fluctuations in medical versus surgically treated glaucomatous patients. J Ocul Pharmacol Ther 2002; 18:489-498.
37. Konstas AG, Topouzis F, Leliopoulou O, et al. 24-hour intraocular pressure control with maximum medical therapy compared with surgery in patients with advanced open-angle glaucoma. Ophthalmology 2006; 113:761-765.
38. Mansouri K, Orguel S, Mermoud A, et al. Quality of diurnal intraocular pressure control in primary open-angle patients treated with latanoprost compared with surgically treated glaucoma patients: a prospective trial. Br J Ophthalmol 2008; 92:332-336.
39. Gordon MO, Beiser JA, Brandt JD, et al. The ocular hypertension treatment study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002; 120:714-720.
40. Medeiros FA, Sample PA, Zangwill LM, et al. Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy. Am J Ophthalmol 2003; 136:805-813.
41. Europeon Glaucoma Prevention Study (EGPS) Group, Miglior S, Pfeiffer N, Torri V, et al. Predictive factors for open-angle glaucoma among patients with ocular hypertension in the Europeon Glaucoma Prevention Study. Ophthalmology 2007; 114:3-9.
42. Ocular Hypertension Treatment Study Group; Europeon Glaucoma Prevention Study Group; Gordon MO, Torri V, Miglior S, et al. Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension. Ophthalmology 2007; 114:10-19.
43. Kim JW, Chen PP. Central corneal pachymetry and visual field progression in patients with open-angle glaucoma. Ophthalmology 2004; 111:2126-2132.
44. Leske MC, Heijl A, Hyman L, et al. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 2007; 114:1965-1972.
45. Ehlers N, Hansen FK, Aasved H. Biometric correlations of corneal thickness. Acta Ophthalmol (Copenh) 1975; 53:652-659.
46. Copt RP, Thomas R, Mermoud A. Corneal thickness in ocular hypertension, primary open-angle glaucoma, and normal tension glaucoma. Arch Ophthalmol 1999; 117:14-16.
47. Herndon LW, Choudhri SA, Cox T, et al. Central corneal thickness in normal, glaucomatous, and ocular hypertensive eyes. Arch Ophthalmol 1997; 115:1137-1141.
48. Liu J, Roberts CJ. Influence of corneal biomechanical properties on intraocular pressure measurement. J Cataract Refract Surg 2005; 31:146-155.
49. Pepose JS, Feigenbaum SK, Qazi MA, et al. Changes in corneal biomechanics and intraocular pressure following LASIK using static, dynamic, and noncontact tonometry. Am J Ophthalmol 2007; 143:39-47.
50. Kotecha A, Elsheikh A, Roberts CR, et al. Corneal thickness- and age-related biomechanical properties of the cornea measured with the ocular response analyzer. Invest Ophthalmol Vis Sci 2006; 47:5337-5347.
51. Congdon NG, Broman AT, Bandeen-Roche K, et al. Central corneal thickness and corneal hysteresis associated with glaucoma damage. Am J Ophthalmol 2006; 141:868-875.
52. Wells AP, Garway-Heath DF, Poostchi A, et al. Corneal hysteresis but not corneal thickness correlates with optic nerve surface compliance in glaucoma patients. Invest Ophthalmol Vis Sci 2008; 49:3262-3268.
53. Mosaed S, Chamberlain WD, Liu JH, et al. Association of corneal thickness and 24-hour intraocular pressure fluctuation. J Glaucoma 2008; 17:85-88.
54. Kida T, Liu JH, Weinreb RN. Effect of 24-hour corneal biomechanical changes on intraocular pressure measurement. Invest Ophthalmol Vis Sci 2006; 47:4422-4426.
55. Kida T, Liu JH, Weinreb RN. Effects of aging on corneal biomechanical properties and their impact on 24-hour measurement of intraocular pressure. Am J Ophthalmol 2008; 146:567-572.